During the past decade, Hospital Perola Byington conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Perola Byington" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Beneficência Portuguesa de São Paulo" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "Daniela de Fátima Teixeira da Silva" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Perola Byington" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Perola Byington" are "Breast Cancer" (10 trials), "Breast Neoplasm Female" (2 trials), "Breast Neoplasms" (2 trials), "Quality of Life" (2 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Perola Byington" in a lesser frequency.

Most popular intervention types in "Hospital Perola Byington" are "Drug" (22 trials), "Radiation" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (9 trials), "Trastuzumab" (8 trials), "Docetaxel" (7 trials), "Paclitaxel" (7 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Perola Byington" are 15 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Perola Byington". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Hospital Perola Byington, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Perola Byington, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".